ReviewCancers2023

Inhibition of Anaplastic Lymphoma Kinase (Alk) as Therapeutic Target to Improve Brain Function in Neurofibromatosis Type 1 (Nf1).

Joseph B Weiss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.